Picard Medical (PMI) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Picard Medical (PMI) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.47 of bullish evidence against -0.58 bearish.

Picard Medical last closed at $7.23, +5.86% on the session.

Against the IVW growth benchmark the position is +5.19% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

32 graded predictions for PMI so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Picard Medical in the 1st percentile on return on equity, where 100 is best.

Picard Medical is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $15.98M.

StockMap tracks Picard Medical as the 125th largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 66 Moderate Underperform, 58 Neutral, 14 Strong Underperform and 3 Moderate Outperform.

On that composite Picard Medical ranks 85th of 141 in the group, against a group median of -0.24.